1. Vital signs: containment of novel multidrug-resistant organisms and resistance mechanisms—United States, 2006–2017.;Woodworth;MMWR Morb Mortal Wkly Rep,2018
2. Washington State Department of Health. Carbapenem-resistant Enterobacteriaceae (CRE) reporting and other carbapenem-resistant organisms. Tumwater, WA: Washington State Department of Health; 2018. https://www.doh.wa.gov/Portals/1/Documents/5100/420-097-Guideline-CRE.pdf
3. Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America.;Nicolle;Clin Infect Dis,2019
4. CDC. Carbapenem-resistant Enterobacteriaceae (CRE) infection: patient FAQs. Atlanta, GA: US Department of Health and Human Services, CDC; 2015. https://www.cdc.gov/hai/organisms/cre/cre-patientfaq.html
5. CDC. Facility guidance for control of carbapenem-resistant Enterobacteriaceae (CRE): November 2015 update. Atlanta, GA: US Department of Health and Human Services, CDC; 2015. https://www.cdc.gov/hai/pdfs/cre/CRE-guidance-508.pdf